Leadership & Vision

Takeda breaks ground on new treatment manufacturing facility in Thousand Oaks, California, USA

Learn more

New report: The impact of plasma-derived therapies in Europe

Learn more

Takeda Breaks Ground on Commercial Cell Therapy Manufacturing Facility in Lexington, Massachusetts

Learn more

Guided by Our Values: Supporting Global COVID-19 Response

Learn more

A ‘Swiss Cheese’ Approach Can Give Us a Second Chance to Contain COVID-19

Learn more

COVID-19: Working Together to Go Faster for Patients

Learn more

Keeping a Positive Spirit During the Ultimate Disruption

Learn more

Coronavirus: Adjusting Our Business Approach While Serving Our Patients

Learn more

Rajeev Venkayya, President, Global Vaccine Business Unit on the Latest on the Coronavirus and Takeda

Learn more

Shaping the Future of Healthcare: Sustainability and Davos 2020

Learn more

Takeda CEO Sees a Bright Future in Globalized Pharmaceuticals Market

Learn more

Grand Opening of New Dengue Vaccine Manufacturing Plant in Singen, Germany

Learn more

Grand Opening of Takeda’s New Production Facility, Grange Castle, Ireland

Learn more

Takeda Breaks Ground on a State-of-the-Art Facility in Osaka, Japan

Learn more

Strengthening Takeda’s Global Reach by Sustaining Core Values

Learn more

CEO Christophe Weber on Why Takeda’s Unique Corporate Governance Structure Works

Learn more

Ramona Sequeira, President of Takeda's U.S. Business Unit, on the Many Opportunities That Lie Ahead for the “New” Takeda

Learn more

Celebrating Our New Global Reach

Learn more

Takeda’s Transformation: The Next Chapter

Learn more

Perspectives on Confronting and Embracing Disruptions in Healthcare

Learn more

Strengthening Our Global Production Network in Oranienburg

Learn more

Takeda Recognized for Commitment to Quality

Learn more